comparison of different clinical specialists in Mexico. Am J Med Genet 1997; 69:23.
283 283. Williams C, Alderson P, Farsides B. Is nondirectiveness possible within the context of antenatal screening and testing? Soc Sci Med 2002; 54:339.
284 284. Johnston J, Farrell R, Parens E. Supporting women's autonomy in prenatal testing. N Engl J Med 2017; 377(6):505.
285 285. Wiering BM, Albada A, Bensing JM, et al. The influence of dispositional optimism on post‐visit anxiety and risk perception accuracy among breast cancer genetic counselees. Psychooncology 2013; 22:2419.
286 286. Hsia YE. Choosing my children's genes: genetic counseling. In: Lipkin M, Rowley PT, eds. Genetic responsibility. New York: Plenum Press, 1974: 43.
287 287. Pergament E, Pergament D. Reproductive decisions after fetal genetic counseling. Best Pract Res Clin Obstet Gynaecol 2012; 26:517.
288 288. Chapman MA. Predictive testing for adult‐onset genetic disease: ethical and legal implications of the use of linkage analysis for Huntington disease. Am J Hum Genet 1990; 47:1.
289 289. Dufrasne S, Roy M, Galvez M, et al. Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab 2011; 102:494.
290 290. Marteau TM, Nippert I, Hall S, et al. Outcomes of pregnancies diagnosed with Klinefelter syndrome: the possible influence of health professionals. Prenat Diagn 2002; 22:562.
291 291. Isidor B, Julia S, Saugier‐Veber P, et al. Searching for secondary findings: considering actionability and preserving the right not to know. Eur J Hum Genet 2019; 27:1481.
292 292. Ortega‐Recalde O, Beltrán OI, Gálvez JM, et al. Biallelic HERC1 mutations in a syndromic form of overgrowth and intellectual disability. Clin Genet 2015; 88:e1.
293 293. Chen R, Shi L, Hakenberg J, et al. Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases. Nat Biotechnol 2016; 34:531.
294 294. Schindewolf E, Khalek N, Johnson MP, et al. Expanding the fetal phenotype: prenatal sonographic findings and perinatal outcomes in a cohort of patients with confirmed 22q11.2 deletion syndrome. Am J Med Genet A 2018; 176:1735.
295 295. Rose NC, Benn P, Milunsky A. Current controversies in prenatal diagnosis: should NIPT routinely include microdeletions/microduplications? Prenat Diagn 2016; 36:10.
296 296. O'Connell O, Meaney S, O'Donoghue K. Anencephaly: the maternal experience of continuing with the pregnancy. Incompatible with life but not with love. Midwifery 2019; 71:12.
297 297. Skirton H. More than an information service: are counselling skills needed by genetic professionals in the genomic era? Eur J Hum Genet 2018; 26:1239.
298 298. Katz J. The silent world of doctor and patient. New York: Free Press, 1984.
299 299. Lantos JD. Should we always tell children the truth? Perspect Biol Med 1996; 40:78.
300 300. Wright CF, Parker M, Lucassen AM. When genomic medicine reveals misattributed genetic relationships – the debate about disclosure revisited. Genet Med 2019; 21:97.
301 301. Nuffield Council on Bioethics. Donor conception: ethical aspects of information sharing. London: Nuffield Council on Bioethics, 2013.
302 302. Bellis MA, Hughes K, Hughes S, et al. Measuring paternal discrepancy and its public health consequences. J Epidemiol Community Health 2005; 59:749.
303 303. Kayser M. Forensic use of Y‐chromosome DNA: a general overview. Hum Genet 2017; 136:621.
304 304. Avci E. Should physicians tell the truth without taking social complications into account? A striking case. Med Health Care Philos 2018; 21:23.
305 305. Brown K. Genetic counseling: legal issues surrounding nondisclosure of paternity. J Leg Med 2008; 29:345.
306 306. Hercher L, Jamal L. An old problem in a new age: revisiting the clinical dilemma of misattributed paternity. Appl Transl Genom 2016; 8:36.
307 307. Lowe G, Pugh J, Kahane G, et al. How should we deal with misattributed paternity? A survey of lay public attitudes. AJOB Empir Bioeth 2017; 8:234.
308 308. Prero MY, Strenk M, Garrett J, et al. Disclosure of misattributed paternity. Pediatrics 2019; 143:e20183899.
309 309. Beauchamp T, Childress J. Principles of biomedical ethics. Oxford: Oxford University Press, 2013.
310 310. Gert B, Culver CM, Clouser KD. Bioethics: a systematic approach, 2nd edn. New York: Oxford University Press, 2006.
311 311. Josen AR, Siegler M, Winslade WJ. Clinical ethics: a practical approach to ethical decisions in clinical medicine. New York: McGraw Hill, 2010.
312 312. Chico V. Reasonable expectations of privacy in non‐disclosure of familial genetic risk: what is it reasonable to expect? Eur J Med Genet 2019; 62:308.
313 313. Lucast EK. Informed consent and the mis attributed paternity problem in genetic counseling. Bioethics 2007; 21:41.
314 314. Weil J, Ormond K, Peters J, et al. The relationship of nondirectiveness to genetic counseling: report of a workshop at the 2003 NSGC Annual Education Conference. J Genet Couns 2006; 15:85.
315 315. American Medical Association. Code of Medical Ethics § 2.131 Disclosure of familial risk in genetic testing, 2014–2015. Chicago, IL: American Medical Association, 2015.
316 316. American Society of Human Genetics, Social Issues Subcommittee on Familial Disclosure. Professional disclosure of familial genetic information. Am J Hum Genet 1998; 62:474.
317 317. National Society of Genetic Counselors. NSGC Code of Ethics sec. II, pt. 7.
318 318. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Screening and counseling for genetic conditions. Washington, DC: US Government Printing Office, 1983:478.
319 319. US Department of Health and Human Services, Office for Civil Rights. Standards for privacy of individually identifiable health information. Code of Federal Regulations vol. 45, parts 160, 164 (2002), as amended (2013).
320 320. Capron AM. Autonomy, confidentiality and quality care in genetic counseling. In: Capron AM, Lappe M, Murray RF, et al., eds. Genetic counseling: facts, values and norms. New York: Alan R. Liss, 1979:307.
321 321. Menko FH, Aalfs CM, Henneman L, et al. Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 2013; 12:319.
322 322. Lacroix M, Nycum G, Godard B, et al. Should physicians warn patients' relatives of genetic risk? Can Med Assoc J 2008; 178:593.
323 323. Van den Heuvel LM, Huisinga MJ, Hoedemaekers YM, et al. Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counselees. Eur J Hum Genet 2019; 27:1341.
324 324. Dove ES, Chico V, Fay M, et al. Familial genetic risks: How can we better navigate patient confidentiality and appropriate risk disclosure to relatives? J Med Ethics 2019; 45:504.
325 325. Dufrasne S, Roy M, Galvez M, et al. Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab 2011; 102:494.
326 326. Van Haecke DD, de Montgolfier S. Genetic diseases and information to relatives: practical and ethical issues for professionals after introduction of a legal framework in France. Eur J Hum Genet 2018; 26:786.
327 327. Falk MJ, Dugan RB, O'Riordan MA, et al. Medical geneticists' duty to warn at‐risk relatives for genetic disease. Am J Med Genet 2003; 120A:374.
328 328. Milunsky A. Genetic disorders and the fetus: diagnosis, prevention, and treatment, 2nd edn. New York: Plenum Press, 1986.
329 329. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in the earliest weeks of pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262:2847.
330 330. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131.
331 331.